Evidence map›Paper›PMID 41094677›Full record

ArticlePediatric rheumatology online journal2025

Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multi-centre cross-sectional study by PRES vaccination working party.

Despoina Maritsi, Noa Alpert, Masa Bizjak, Amit Ziv, Barbora Balaziova, Mehmet Yildiz, Alenka Gagro, Mario Sestan, Aygul Khabirova, Betul Sozeri and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Pediatric rheumatology online journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Despoina MaritsiInfectious Diseases, Immunology and Rheumatology Unit, Second Department of Pediatrics, Athens Medical School, Athens, Greece.
Noa AlpertPediatric Rheumatology Unit, Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel.
Masa BizjakDepartment of Allergy, Rheumatology, Immunology UCH Ljubljana, UMC Ljubljana, Ljubljana, Slovenia.
Amit ZivPediatric Rheumatology Unit, Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel.
Barbora BalaziovaDepartment of Paediatrics, Comenius University Medical School in Bratislava, National Institute of Children's Diseases, Bratislava, Slovakia.
Mehmet YildizDepartment of Pediatric Rheumatology, Istanbul University, Cerrahpasa, Turkey.
Alenka GagroDepartment of Pediatrics, Children's Hospital Zagreb, Zagreb, Croatia.
Mario SestanDepartment of Paediatrics, University of Zagreb School of Medicine, Zagreb, Croatia.
Aygul KhabirovaSaint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russian Federation.
Betul SozeriUmraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Sengul CaglayanUmraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Marija JelusicDepartment of Paediatrics, University of Zagreb School of Medicine, Zagreb, Croatia.
Violetta Opoka-WiniarskaDepartment of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Lublin, Poland.
Mikhail KostikSaint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russian Federation.
Claudia BracagliaDivision of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.
Francesca MinoiaFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Tomas DallosDepartment of Paediatrics, Comenius University Medical School in Bratislava, National Institute of Children's Diseases, Bratislava, Slovakia.
Ozgur KasapcopurDepartment of Pediatric Rheumatology, Istanbul University, Cerrahpasa, Turkey.
Natasa ToplakDepartment of Allergy, Rheumatology, Immunology UCH Ljubljana, UMC Ljubljana, Ljubljana, Slovenia. natasa.toplak@kclj.si.
Yosef UzielPediatric Rheumatology Unit, Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel.
Panagiota TsagkliInfectious Diseases, Immunology and Rheumatology Unit, Second Department of Pediatrics, Athens Medical School, Athens, Greece.
Merav Heshin-BekensteinGrey Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

Funding

University Medical Center Ljubljana 20250018
6 · The paper itself

Abstract

backgroundChildren with rheumatic diseases are at risk for contracting severe influenza and COVID-19 and are thus targeted for these vaccination.

objectivesTo assess the influenza (flu) vaccination rate in children with Juvenile Idiopathic Arthritis (JIA), investigate families' attitudes towards the influenza vaccine, and the effect of the COVID-19 pandemic on flu vaccine uptake.

methodsThis multi-centre, cross-sectional study was conducted across 9 countries. JIA caregivers completed an anonymous questionnaire about their children's influenza vaccination, including the 2019-2020 and 2020-2021 seasons, including knowledge, and perceptions regarding influenza vaccination.

resultsBased on responses from 655 JIA caregivers, 152 children (23.2%) received influenza vaccinations in the 2020-2021 season, representing a significant rise from 18.6% in the previous season (p < 0.01). The likelihood of vaccination was higher among employed/self-employed caregivers compared to unemployed (28.2% and 29.9% vs. 13.9%), and those with tertiary education versus elementary (28% vs. 9.7%), both p < 0.01. Concerns of children's vulnerability to SARS-CoV-2 and severe COVID-19 disease due to JIA were prevalent (51.3% and 85.3% respectively), with 51.3% supporting COVID-19 vaccination. Caregivers who previously vaccinated their children for influenza showed a greater inclination towards SARS-CoV-2 vaccination (73.4% and 79.5%, p < 0.01).

conclusionsFamilies of children with JIA reported an increasing flu vaccine uptake and a high intention for COVID-19 vaccine administration. Previous vaccination behavior was shown as a significant predictor of future behaviour. Strengthening health education may address fears and lead to better vaccine coverage against both influenza and SARS-CoV-2 in children with JIA and other inflammatory rheumatic diseases.

Indexed as

Arthritis, JuvenileCOVID-19Health Knowledge, Attitudes, PracticeInfluenza, HumanInfluenza VaccinesVaccinationAdolescentCaregiversChildCross-Sectional StudiesFemaleHumansMaleSARS-CoV-2Surveys and QuestionnairesInfluenza VaccinesChildrenCOVID-19Influenza vaccineJuvenile Idiopathic Arthritis (JIA)Vaccination

Identifiers

PMID41094677
PMCPMC12522407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.